Loading viewer...
investor_presentation
Format: PDF investor_presentation
ResMed Q4 2016 investor presentation highlighting the company's 27+ year track record as a global leader in respiratory and sleep apnea treatment solutions. The presentation outlines ResMed's innovative product portfolio across sleep apnea, COPD, and neuromuscular diseases, with over 5,000 patents and worldwide presence in 100+ countries.
investor_presentation
41 Pages
investor_presentation
15 Pages
Kerry Group
Mahindra & Mahindra 2024 Investor Conference Presentation
investor_presentationinvestor_presentation
12 Pages
Mahindra & Mahindra Limited
Phibro Animal Health Investor Presentation — November 2017
investor_presentationinvestor_presentation
12 Pages
Phibro Animal Health Corporation